MDGL
NASDAQ · Biotechnology
Madrigal Pharmaceuticals Inc
$515.25
-3.58 (-0.69%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+16.22%
YTD
-13.24%
Open$523.72
Previous Close$518.83
Day High$526.00
Day Low$502.63
52W High$615.00
52W Low$393.61
Volume—
Avg Volume208.3K
Market Cap12.35B
P/E Ratio—
EPS$-12.87
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$526.21
Below
SMA 200
$421.32
Above
RSI (14)
32.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
24 analysts
Price Target
-76.7% upside
Current
$515.25
$515.25
Target
$119.83
$119.83
$78.20
$119.83 avg
$127.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 992.37M | 3.52B | 3.21B |
| Net Income | -298,499,056 | -1,086,916,353 | -1,008,552,409 |
| Profit Margin | -30.1% | -30.9% | -31.4% |
| EBITDA | -312,048,717 | -994,214,061 | -913,486,769 |
| Free Cash Flow | — | -874,407,524 | -958,278,915 |
| Rev Growth | — | +9.6% | -7.9% |
| Debt/Equity | 0.56 | 0.46 | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.99 | -0.08% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $406.46 | -0.92% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.37 | -1.51% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $799.26 | -0.58% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $246.45 | -2.07% | 40.0 | 32.33B |